EXECUTIVE SUMMARY
Apotex is a Canadian pharmaceutical company that was founded in 1979, Toronto Canada.
Apotex deals with the production and distribution of generic drugs. These drugs come in various
dosage forms such as liquid, injectables, ophthalmia and nasal sprays. Likewise produces over
300 drugs in 4000 dosage.
Some products include Bisoprolol, Ciprofloxacin, Plavix, Paroxetine, Advil, Lansoprazole,
Amlodipine, Omeprazole and many more.
Apotex stands as No. 1 in the pharmaceutical market for producing generic drug and exports
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
these medical equipment, non-prescription and private label medicines in disposable plastic and
packaging component for medical use to over 115 countries across the globe which include UK,
Netherlands, Turkey, Mexico, Belgium, Poland, New Zealand, etc.
The main purpose for this report is to analyse the pharmaceutical sector in Japan and establish
the best strategy to which Apotex can export drugs to Japan that is in line with Apotex values and
sh
Th
vision.
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
TABLE OF CONTENT
0 EXECUTIVE SUMMARY
CHAPTER I
COMPANY ANALYSIS
Introduction………………………...2
Company overview…………………3
Purpose Statement………….……...4
Mission and Value………………….5
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
Business Models…………………….6
Objectives…………………………….7
Culture and Diversity……………….8
Corporate Social Responsibility…….9
sh
Th
SWOT Analysis...……………………10
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
INTRODUCTION
A nations mortality rate can be influenced by the state of health its citizens, which is why the
pharmaceutical sector is a very important part of the economy. Generic pharmaceuticals in
Canada and in the world is huge and has various potentials for generic drug producer to be
productive. With the various outbreak of incommunicable and communicable diseases, terminal
diseases, and many more around the world, Apotex Canada’s biggest generic drug producer and
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
many other manufacturers is presented with opportunities to introduce and sell out brand
marketed drugs.
Therefore, the purposed reason of this project is analyzing the SWOT of Apotex including its
external and internal environment in order to discover potential that exist in Japan for Apotex
and apply strategies for success in the pharmaceutical market.
Based on the evaluation that will be carried out on this report. a means of exporting as well as
channels of distribution will be identified.
Recommendations will also be given to the company on market and the best measures to
sh
Th
increase its resources to ascertain the organizations goals.
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
Company Overview
Apotex Inc. a Canadian pharmaceutical company founded by the Late Barry Sherman in 1974, is
the fastest growing manufacturer of high-quality and affordable medicine (generic drugs) in
Canada and the 7th globally. Apotex has employed more than 10,000 people in over the
45countries they operate in, which also makes it possible for them to markets over 300 drugs
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
producing 25 billion dosages per year to more than 115 countries across the globe.
APOTEX PURPOSE AND MISSION STATEMENT
PURPOSE STATEMENT
‘’Improving access to medicines for millions of patients worldwide. We do this by providing
affordable innovative and high-quality solutions (“About Apotex”, 2018).
Th
MISSION STATEMENT
sh
‘’Apotex is an independent, dynamic, Canadian pharmaceutical company committed to R&D,
manufacturing and distributing a broad range of high-quality affordable medicines to patients,
healthcare providers, payers and government worldwide. We will always meet global regulatory,
quality and compliance requirements. We value and respect our employees, our business
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
partners, our suppliers, our customers and the communities we serve while operating with
accountability and integrity in everything we do’’ (“About Apotex”, 2018).
VALUE
“Apotex core value is centered on producing and marketing quality goods.
The company’s value is to help everyone to know what is right from wrong; they help us to
determine if we are on the right path and fulfilling the business goals’’(“About Apotex”, 2018).
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
BUSINESS MODEL
Apotex Pharmaceuticals have developed a deep understanding of the global market and the skills
and experience needed to succeed in the areas of sales, marketing, product development, clinical
development, regulatory and medical affairs over their years of operations ("Business
Development", 2018). Apotex business model includes the different sectors used in delivering
their business values, and this includes the use of active pharmaceutical ingredients whereby the
Apotex Pharma hem sector is in charge of overseeing that division, the Apo-Pharma, APOTEX
Fermentation, and AVEVA CA gene are in charge of delivering the company’s R&D facilities;
the Apotex Bio Clinical development sector is also in charge
of the company’s clinical
development, and ACCUCAPS & ARPL is in charge of the finished goods and production, while
Th
the affiliate network and distributors are in charge of the marketing and distribution of the
sh
pharmaceutical products ("APOTEX Corporate Philanthropy Report", n.d.).
OBJECTIVES
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
Apotex is committed to being one of the world’s leading suppliers of quality, affordable
medications. (About Apotex, 2018).
CULTURE & DIVERSITY
According to Australia| Apotex worldwide, ‘‘A very huge plus for Apotex is that it has a very
diverse workforce made up of various cultures and ethnicity. A place where employees are
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
respected.’’ (our-culture-and-diversity),
"We strive to achieve a workplace where people enjoy coming to work, are passionate about
what they do, love the people they work with and respect each other and the Apotex
values."(Apotex,2018).
The company also embraces collective differences and support the strengths and opportunities
that individual differences bring to Apotex.
Th
CORPORATE SOCIAL RESPONSIBILITY
sh
Apotex as a global organization supports the community in which they live in. Apotex is also
committed to supporting ‘’The United Way’’ by contributing over 11 million and is the largest
donor in the Canadian pharmaceutical industry.
The company being a top donor also partners with Health Partners Canada International (HPIC)
whose goal is to increase access to medicine in vulnerable communities.
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
Apotex also supports institutions where many of their workers and employees have studied, by
donating $23 million to universities across Canada since 2001 and has established an APO
campus program which provides students to join Apotex as a summer student or on internship
position.
Environmentally wise, Apotex works to increase the acquisition of recyclable material and
products and conserve natural resources.
SWOT ANALYSIS
Strength: Apotex major strength has been its ability to stay on top and remain Canada’s No 1
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
producer for generic drugs against all other pharmaceutical companies. Apotex has become
nation wide and has created brand name awareness in over 115 countries it exports to. The
company has also reduced the high rate of dependence of drugs from a specific market which
also creates huge profit making for them. (Apotex, Inc: Pharmaceutical & Healthcare, 2014).
Most importantly, the company’s strategy to focus on R&D has been the biggest advantage
Apotex has over other companies. Apo Pharma Inc. is a subsidiary arm of the company that deals
with conducting of research on new chemical entities and product for rising new diseases and
illnesses. In 2007, Apotex’s R&D expenditure was $181million (Apotex, Inc.: Pharmaceuticals
& Healthcare, 2014). Hence the current positioning and strategy of the company, it has a
Th
competitive advantage compared to other pharmaceutical company in Canada.
sh
Weakness: Apotex has experienced some setbacks in the past ranging from lawsuits to product
recalls all of which casts a bad image for the company. 1n 2011, the company lost a patent
infringement lawsuit to Alcon, a U.S based medical company and the company had previously
lost another law suit in the past (Apotex, Inc.: Pharmaceuticals & Healthcare, 2014).
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
Also, the company suffered a huge economic loss and set back in 2009 when they had to recall
their product because of a discovered excessive specification of a compound in one of their drugs
(Apotex, Inc.: Pharmaceuticals & Healthcare, 2014). All these events had grave impact for the
company images and hence the company will need to work extra hard to prove itself and regain
customer confidence.
Opportunities: There has been lots of outbreaks and illnesses in various parts of the world.
Some other countries have reported a low death rate or life expectancy rate because of issues like
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
obesity respiratory illness amongst others (Apotex, Inc.: Pharmaceuticals & Healthcare, 2014).
This poses a huge opportunity for Apotex the maximize their huge capacity in R&D to meet the
medical needs of these countries around the world.
Also, there has been reports of infectious diseases due to climate change, environmental and
cultural factors. All of these offers the company an opportunity to have a wide range of product
portfolio which will not only out the company at an advantageous position in Canada but also
globally.
sh
Th
Threats: The biggest threat for Apotex are the competitors including companies like Johnson&
Johnson, GlaxoSmithKline, and Sandoz amongst others who are also making strategic moves to
be the best in the industry. Another huge threat are political issues involving tight regulations and
tariffs on the drug market and trading which can threaten revenue and increase overall
expenditure when exporting. Also, regional economic unions such as EU can pose a huge threat
to exporting
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
REFERENCES
About Apotex (2018)
apotex.com
Retrieved at 15
November
2018
from
is
ar stu
ed d
vi y re
aC s
o
ou urc
rs e
eH w
er as
o.
co
m
http://www.apotex.com/ca/en/about/default.a sp
About Apotex (2018)
www1.apotex.com Retrieved at 15 November
2018
from
http://www1.apotex.com/global/about-us/about-apotex
Apotex (2018)
2018 from
Culture and Diversity
www1.Apotex.com Retrieved at 20 November
http://www1.apotex.com/au/careers/our-culture-and-diversity
Apotex (2018) Corporate Responsibility www1.apotex.com Retrieved
2018 from
at
20 November
http://www1.apotex.com/global/about-us/corporate-responsibility
Th
Apotex (2018) Swot Analysis
Retrieved
at
20 November 2018
from
sh
https://www.google.ca/search?
q=swot+analysis+of+apotex&rlz=1C1CHBF_enCA815CA815&tbm=isch&source=iu&ictx=1&f
ir=j6WMdHV8t2rAxM%253A%252C4YdAtA3Bph8L7M%252C_&usg=AI4_kRuAmlopa_OEFozRlYhShSn_0ncjw&sa=X&ved=2ahUKEwjv55HIyc3eAhUMT98KHbVuA4
EQ9QEwAnoECAQQBA#imgrc=j6WMdHV8t2rAxM:
This study source was downloaded by 100000830558815 from CourseHero.com on 10-19-2021 08:17:54 GMT -05:00
https://www.coursehero.com/file/57962118/Company-Analysis-of-Apotexdocx/
Powered by TCPDF (www.tcpdf.org)